Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 04 - 28    tags : Disease    save search

AbbVie Unites with Plexium to Leverage Protein Degraders Against Neurological Diseases
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.0% C: 0.0%

neurological disease
AbbVie Unites with Plexium to Leverage Protein Degradation Against Neurological Diseases
Published: 2022-04-28 (Crawled : 21:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.0% C: 0.0%

neurological disease
Vaxxinity Completes Enrollment in Part B of UB-312 Phase 1 Clinical Trial for Parkinson’s Disease
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
VAXX | $0.13 -35.0% -53.85% 4.6M twitter stocktwits trandingview |
| | O: -1.94% H: 8.76% C: 6.5%

ub-312 disease trial enroll phase 1
USD 438.03 Mn growth expected in Krabbe Disease Treatment Market | North America to emerge as key market | Technavio
Published: 2022-04-28 (Crawled : 16:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380 twitter stocktwits trandingview |
Health Technology
| | O: 1.95% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -14.18% 2.6K twitter stocktwits trandingview |
Health Technology
| | O: -3.19% H: 1.56% C: 1.56%
NVSEF | News | $96.0 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: -0.44% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.59% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.0% C: 0.0%

america treatment disease growth market
OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases
Published: 2022-04-28 (Crawled : 10:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| | O: -2.96% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -2.36% H: 0.0% C: 0.0%

rare drug immunology therapeutics disease
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.